case report | Q2782326 |
scholarly article | Q13442814 |
P356 | DOI | 10.3350/CMH.2015.0040 |
P8608 | Fatcat ID | release_rxjhkl4pzzabdikz3sagmqtkni |
P932 | PMC publication ID | 4946399 |
P698 | PubMed publication ID | 27246353 |
P2093 | author name string | Sang Hyun Kim | |
Yeon Seok Seo | |||
Ho Sang Ryu | |||
Soon Ho Um | |||
Han Ah Lee | |||
Seung Woon Park | |||
Sun Young Yim | |||
Yura Sim | |||
P2860 | cites work | Autoimmune hepatitis--Update 2015 | Q28081791 |
Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis | Q28248157 | ||
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 | ||
Diagnosis and management of autoimmune hepatitis | Q34118165 | ||
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy | Q34286525 | ||
Clinical pharmacology and pharmacogenetics of thiopurines | Q34782066 | ||
Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational study | Q34825783 | ||
Treatment strategies in autoimmune hepatitis | Q34936764 | ||
Current and future treatments of autoimmune hepatitis | Q37503380 | ||
Autoimmune hepatitis: a comprehensive review | Q38065506 | ||
Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes | Q41081740 | ||
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis. | Q43244249 | ||
Mycophenolate mofetil as second line therapy in autoimmune hepatitis? | Q46317682 | ||
Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. | Q53160616 | ||
Thiopurine Methyltransferase in Humans: Development and Tissue Distribution | Q67885458 | ||
Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival | Q72122015 | ||
[Liver, blood proteins and food proteins] | Q73958348 | ||
Lupoid hepatitis | Q74334969 | ||
Safety issues in the management of autoimmune hepatitis | Q81230534 | ||
Autoimmune hepatitis | Q82936688 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | autoimmune hepatitis | Q786844 |
P304 | page(s) | 281-285 | |
P577 | publication date | 2016-06-01 | |
P1433 | published in | Clinical and molecular hepatology | Q26853927 |
P1476 | title | Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis | |
P478 | volume | 22 |
Q42358509 | Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments |
Q55428911 | Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta-analysis. |
Q44247097 | Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba |
Q90379391 | Human Cytomegalovirus Upregulates Expression of HCLS1 Resulting in Increased Cell Motility and Transendothelial Migration during Latency |